Seeking Alpha

Goldman recommends buying Allergan (AGN +0.2%) on its recent pullback, saying the company is...

Goldman recommends buying Allergan (AGN +0.2%) on its recent pullback, saying the company is well positioned with its diversified portfolio, emerging market exposure, and high growth potential. The firm reiterates its Buy rating with a $106 price target.
From other sites
Comments (1)
  • viper32nc1
    , contributor
    Comments (95) | Send Message
     
    If Goldman Sachs is telling you to buy it, it's because they are shorting it!
    25 May 2012, 10:39 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs